Literature DB >> 4586147

Inducible and constitutive resistance to macrolide antibiotics and lincomycin in clinically isolated strains of Streptococcus pyogenes.

S L Hyder, M M Streitfeld.   

Abstract

STUDIES ON ERYTHROMYCIN RESISTANCE IN STRAINS OF GROUP A STREPTOCOCCI INDICATED THAT THEY WERE COMPRISED OF TWO TYPES: (i) an inducible, resistant type (IR strains) was seen, which manifested immediate logarithmic growth in media containing high concentrations of the drug only after brief previous exposure (induction period) of the organisms to subinhibitory concentrations of erythromycin, and (ii) a constitutive, resistant type (CR strains) which demonstrated, without prior drug exposure, continued logarithmic growth in media containing high concentrations of erythromycin. Subinhibitory concentrations of either chloramphenicol or puromycin, when added to IR strains prior to induction, interfered with their induction by erythromycin. Exposure of CR strains to chloramphenicol did not visibly affect the subsequent growth curve of these strains in media containing high concentrations of erythromycin. In IR strains, resistance to other macrolide antibiotics (oleandomycin, spiramycin, carbomycin, magnamycin) and to lincomycin also was inducible in nature. There was cross-inducibility between erythromycin, other macrolide antibiotics, and lincomycin. CR strains were constitutively resistant to these antibiotics.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4586147      PMCID: PMC444551          DOI: 10.1128/AAC.4.3.327

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  The erythromycin group of antibiotics.

Authors:  L P GARROD
Journal:  Br Med J       Date:  1957-07-13

2.  Sensitivity and resistance to erythromycin in Bacillus subtilis 168: the ribosomal binding of erythromycin and chloramphenicol.

Authors:  S B Taubman; N R Jones; F E Young; J W Corcoran
Journal:  Biochim Biophys Acta       Date:  1966-08-17

3.  Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin.

Authors:  E Sanders; M T Foster; D Scott
Journal:  N Engl J Med       Date:  1968-03-07       Impact factor: 91.245

4.  The binding of chloramphenicol by ribosomes from Bacillus megaterium.

Authors:  D Vazquez
Journal:  Biochem Biophys Res Commun       Date:  1964-04-22       Impact factor: 3.575

5.  The problems of drug-resistant pathogenic bacteria. Macrolide resistance in staphylococci.

Authors:  T Saito; M Shimizu; S Mitsuhashi
Journal:  Ann N Y Acad Sci       Date:  1971-06-11       Impact factor: 5.691

6.  Lincomycin, an inhibitor of aminoacyl sRNA binding to ribosomes.

Authors:  F N Chang; C J Sih; B Weisblum
Journal:  Proc Natl Acad Sci U S A       Date:  1966-02       Impact factor: 11.205

7.  The stoichiometry of erythromycin binding to ribosomal particles of Staphylococcus aureus.

Authors:  J C Mao
Journal:  Biochem Pharmacol       Date:  1967-12       Impact factor: 5.858

8.  Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction.

Authors:  B Weisblum; C Siddhikol; C J Lai; V Demohn
Journal:  J Bacteriol       Date:  1971-06       Impact factor: 3.490

9.  Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved.

Authors:  B Weisblum; V Demohn
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

10.  Transduction of resistance to chlortetracycline and novobiocin in Staphylococcus aureus.

Authors:  P A PATTEE; J N BALDWIN
Journal:  J Bacteriol       Date:  1961-12       Impact factor: 3.490

View more
  26 in total

1.  Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.

Authors:  M P Montanari; M Mingoia; E Giovanetti; P E Varaldo
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.

Authors:  E Giovanetti; M P Montanari; M Mingoia; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

3.  Inactivation of the lipopeptide antibiotic daptomycin by hydrolytic mechanisms.

Authors:  Vanessa M D'Costa; Tariq A Mukhtar; Tejal Patel; Kalinka Koteva; Nicholas Waglechner; Donald W Hughes; Gerard D Wright; Gianfranco De Pascale
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

4.  Development of high-level streptomycin resistance affected by a plasmid in lactic streptococci.

Authors:  R P Sinha
Journal:  Appl Environ Microbiol       Date:  1986-08       Impact factor: 4.792

5.  Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.

Authors:  J Kataja; P Huovinen; M Skurnik; H Seppälä
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

6.  Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens.

Authors:  C Agouridas; A Bonnefoy; J F Chantot
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

7.  Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin.

Authors:  Karel Urbánek; Milan Kolár; Luboslava Cekanová
Journal:  Pharm World Sci       Date:  2005-04

8.  Plasmid-determined resistance to erythromycin: comparison of strains of streptococcus faecalis and streptococcus pyogenes with regard to plasmid hmology and resistance inducibility.

Authors:  Y Yag; A E Franke; D B Clewell
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

9.  Systematic difference in the methylation of ribosomal ribonucleic acid from gram-positive and gram-negative bacteria.

Authors:  T Tanaka; B Weisblum
Journal:  J Bacteriol       Date:  1975-08       Impact factor: 3.490

10.  A family of r-determinants in Streptomyces spp. that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibiotics.

Authors:  Y Fujisawa; B Weisblum
Journal:  J Bacteriol       Date:  1981-05       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.